Element Materials Technology is pleased to announce that it has completed the formal rebranding and integration of MDT, Medical Device Testing Services, significantly expanding its global medical device testing capability and capacity. Acquired on the 1st of April 2017, the integration strengthens Element’s capabilities in commercial cardiovascular and medical device testing.
The state of the art laboratory based in Minnetonka, Minnesota is the largest cardiovascular, A2LA accredited, testing facility operating in the USA, with over $6 million invested in commercial fatigue and durability test systems, inspection instruments and test fixturing inventory. The laboratory specializes in pulsatile, axial, and bending fatigue on stents, catheters, and heart valves, as well as neurostimulation devices.
Rick Sluiters, EVP Aerospace, Element, commented: ‘’We are delighted to formally welcome MDT to the Element Group. The laboratory complements our existing medical device testing business internationally, demonstrating Element’s commitment to becoming the recognized market leader for medical device testing.
“Together with the more recent acquisition of Exova, Element now offers a broad set of capabilities in engineering, materials, microbiology and chemistry that provide our customer with one stop technology services for medical device development and testing.’’
Element is one of the world’s leading providers of testing, inspection and certification services to the international medical device sector, with 32 laboratories focusing on medical device testing located in the Americas and Europe. The laboratories provide a comprehensive range of mechanical testing and product qualification testing on hip, knee & spinal implants; trauma devices; cardiovascular & orthopaedic devices, and implantable, diagnostic and therapeutic equipment. Element offers consulting and testing services in prototype development, polymer synthesis and materials selection, coatings and adhesives, 510(k) and CE submissions and a wide range of failure and contaminant investigation capabilities.
